Illinois Governor JB Pritzker has revealed he lost about 80 pounds using GLP-1 medication, advocating for expanded state coverage amid rising discussions on drug costs and public health strategies.
Illinois Governor JB Pritzker has said he has lost about 80 pounds after two years on a GLP-1 medicine, describing the treatment as part of a wider effort to improve his health after a diabetes diagnosis. In an interview with CBS News, he said the drug was prescribed after his doctor warned that he might need long-term treatment, and added that he now injects it weekly, walks roughly four miles most mornings and is no longer using insulin.
Pritzker also used the interview to defend a policy that makes the same class of medication available through the state employee health plan. CBS News reported that Illinois now covers GLP-1 treatment for 55,000 state workers, with the governor arguing that broader access could lower costs over time by reducing obesity- and diabetes-related illness. The state’s benefits documents show that, from 1 July 2024, all plans in the State Employees Group Insurance Programme began covering medically necessary injectable drugs prescribed to improve blood sugar control or support weight loss for adults with pre-diabetes, gestational diabetes or obesity, provided they enrol in a lifestyle management programme.
The coverage sits within a broader package of state employee health options administered by the Illinois Department of Central Management Services, including managed care plans, a consumer-driven option and the Quality Care Health Plan, which gives members wide choice over doctors, hospitals and pharmacies. Prescription coverage is handled through each plan’s pharmacy benefit arrangements, with deductibles and copayments applying according to plan design.
The political context is likely to keep the issue in view. Pritzker, an heir to the Hyatt fortune, has faced renewed speculation about a possible White House run in 2028, although he told CBS he was not trying to reshape his image. He said his own experience was meant to show that the medications can work, while maintaining that the main reason for sharing his story was to encourage others to consider their options. Illinois officials have estimated the GLP-1 expansion could cost about $210 million in its first year, even as outside estimates have suggested the bill may be considerably higher.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
